Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Progression of carotid-artery disease in type 2 diabetic patients: a cohort prospective study.

Bosevski M, Stojanovska L.

Vasc Health Risk Manag. 2015 Oct 16;11:549-53. doi: 10.2147/VHRM.S79079. eCollection 2015.

2.

Arterial stiffness is elevated in normotensive type 2 diabetic patients with peripheral neuropathy.

Chen Q, Chiheb S, Fysekidis M, Jaber Y, Brahimi M, Nguyen MT, Millasseau S, Cosson E, Valensi P.

Nutr Metab Cardiovasc Dis. 2015 Nov;25(11):1041-9. doi: 10.1016/j.numecd.2015.08.001. Epub 2015 Aug 12.

PMID:
26474725
3.

[Low-grade systemic inflammation and the development of metabolic diseases: from the molecular evidence to the clinical practice].

León-Pedroza JI, González-Tapia LA, del Olmo-Gil E, Castellanos-Rodríguez D, Escobedo G, González-Chávez A.

Cir Cir. 2015 Nov-Dec;83(6):543-51. doi: 10.1016/j.circir.2015.05.041. Epub 2015 Jul 6. Review. Spanish.

4.

Poor sleep quality is associated with increased arterial stiffness in Japanese patients with type 2 diabetes mellitus.

Osonoi Y, Mita T, Osonoi T, Saito M, Tamasawa A, Nakayama S, Someya Y, Ishida H, Kanazawa A, Gosho M, Fujitani Y, Watada H.

BMC Endocr Disord. 2015 Jun 18;15:29. doi: 10.1186/s12902-015-0026-1.

6.

Vascular comorbidities in the onset and progression of multiple sclerosis.

Tettey P, Simpson S Jr, Taylor BV, van der Mei IA.

J Neurol Sci. 2014 Dec 15;347(1-2):23-33. doi: 10.1016/j.jns.2014.10.020. Epub 2014 Oct 16. Review.

PMID:
25454639
7.

Gender differences and patterns of cardiovascular risk factors in Type 1 and Type 2 diabetes: a population-based analysis from a Scottish region.

Collier A, Ghosh S, Hair M, Waugh N.

Diabet Med. 2015 Jan;32(1):42-6. doi: 10.1111/dme.12569. Epub 2014 Sep 25.

PMID:
25156218
8.

[Preliminary analysis of the relationship between peripheral arterial disease and other atherosclerosis markers and diabetic nephropathy].

Rioja J, Moreno T, Coca I, Jiménez-Villodres M, Rodríguez-Morata A, Valdivielso P.

Clin Investig Arterioscler. 2014 Sep-Oct;26(5):229-35. doi: 10.1016/j.arteri.2014.02.004. Epub 2014 Apr 5. Spanish.

PMID:
24709377
9.

Daily non-soy legume consumption reverses vascular impairment due to peripheral artery disease.

Zahradka P, Wright B, Weighell W, Blewett H, Baldwin A, O K, Guzman RP, Taylor CG.

Atherosclerosis. 2013 Oct;230(2):310-4. doi: 10.1016/j.atherosclerosis.2013.07.048. Epub 2013 Aug 6.

PMID:
24075762
10.

Non-compressible arterial disease and the risk of coronary calcification in type-2 diabetes.

Lilly SM, Qasim AN, Mulvey CK, Churchill TW, Reilly MP, Eraso LH.

Atherosclerosis. 2013 Sep;230(1):17-22. doi: 10.1016/j.atherosclerosis.2013.06.004. Epub 2013 Jun 28.

PMID:
23958247
11.

Clinical profile of long-term survivors and nonsurvivors with type 2 diabetes.

Mohan V, Shanthi Rani CS, Amutha A, Dhulipala S, Anjana RM, Parathasarathy B, Unnikrishnan R.

Diabetes Care. 2013 Aug;36(8):2190-7. doi: 10.2337/dc12-1193. Epub 2013 Apr 5.

12.

[Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances].

Brath H, Wascher TC, Kästenbauer T, Toplak H.

MMW Fortschr Med. 2012 Jun 28;154 Suppl 2:41-7. German.

PMID:
23424754
13.

Fasting apolipoprotein B48 is a marker for peripheral arterial disease in type 2 diabetes.

Mancera-Romero J, Sánchez-Chaparro MA, Rioja J, Ariza MJ, Olivecrona G, González-Santos P, Valdivielso P.

Acta Diabetol. 2013 Jun;50(3):383-9. doi: 10.1007/s00592-012-0434-x. Epub 2012 Oct 9.

PMID:
23053881
14.

Fasting apolipoprotein B48 is associated with asymptomatic peripheral arterial disease in type 2 diabetic subjects: a case-control study.

Lapice E, Cipriano P, Patti L, Romano G, Vaccaro O, Rivellese AA.

Atherosclerosis. 2012 Aug;223(2):504-6. doi: 10.1016/j.atherosclerosis.2012.05.038. Epub 2012 Jun 13.

PMID:
22762727
15.

Predictors of decrease in ankle-brachial index among patients with diabetes mellitus.

Hoe J, Koh WP, Jin A, Sum CF, Lim SC, Tavintharan S.

Diabet Med. 2012 Sep;29(9):e304-7. doi: 10.1111/j.1464-5491.2012.03705.x.

PMID:
22587456
16.

Achieving secondary prevention low-density lipoprotein particle concentration goals using lipoprotein cholesterol-based data.

Mathews SC, Mallidi J, Kulkarni K, Toth PP, Jones SR.

PLoS One. 2012;7(3):e33692. doi: 10.1371/journal.pone.0033692. Epub 2012 Mar 29.

17.

Toe-brachial index is associated more strongly with albuminuria or glomerular filtration rate than ankle-brachial index in patients with type 2 diabetes.

Fukui M, Tanaka M, Hamaguchi M, Senmaru T, Sakabe K, Asano M, Yamazaki M, Hasegawa G, Imai S, Nakamura N.

Hypertens Res. 2012 Jul;35(7):745-9. doi: 10.1038/hr.2012.16. Epub 2012 Feb 16.

PMID:
22336768
18.

Differential effects of low-carbohydrate and low-fat diets on inflammation and endothelial function in diabetes.

Davis NJ, Crandall JP, Gajavelli S, Berman JW, Tomuta N, Wylie-Rosett J, Katz SD.

J Diabetes Complications. 2011 Nov-Dec;25(6):371-6. doi: 10.1016/j.jdiacomp.2011.08.001. Epub 2011 Oct 27.

PMID:
22036100
19.

Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus.

Gazzaruso C, Coppola A, Montalcini T, Baffero E, Garzaniti A, Pelissero G, Collaviti S, Grugnetti A, Gallotti P, Pujia A, Solerte SB, Giustina A.

Endocrine. 2012 Feb;41(1):89-95. doi: 10.1007/s12020-011-9544-4. Epub 2011 Oct 11.

PMID:
21986921
20.

Intensive glycaemic control in type 2 diabetes mellitus: does it improve cardiovascular outcomes?

Reddy SV, Bhatia E.

Natl Med J India. 2011 Jan-Feb;24(1):21-7. Review.

PMID:
21608354
Items per page

Supplemental Content

Loading ...
Write to the Help Desk